Laddar...

The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1 infected individuals; a randomized clinical trial

BACKGROUND: Hepatic fat is related to insulin resistance (IR) and visceral adipose tissue (VAT) in HIV+ and uninfected individuals. Growth hormone (GH) reduces VAT but increases IR. We evaluated the effects of recombinant human GH (rhGH) and rosiglitazone (Rosi) on hepatic fat in a substudy of a ran...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antivir Ther
Huvudupphovsmän: Kotler, Donald P, He, Qing, Engelson, Ellen S, Albu, Jeanine B, Glesby, Marshall J
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5110034/
https://ncbi.nlm.nih.gov/pubmed/25536669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2927
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!